Yahoo
NYSE - Nasdaq Real Time Price USD

Hinge Health, Inc. (HNGE)

92.37 +1.61 (+1.77%)
At close: September 4 at 4:00:02 PM EDT
92.75 +0.38 (+0.41%)
After hours: September 4 at 7:48:51 PM EDT
Trade HNGE on Coinbase
Chart Range Bar
Loading chart for HNGE
Chart does not reflect overnight price.
  • Previous Close 90.76
  • Open 90.00
  • Bid 91.90 x 30000
  • Ask 93.49 x 50000
  • Day's Range 89.41 - 93.14
  • 52 Week Range 30.08 - 95.57
  • Volume 1,179,003
  • Avg. Volume 1,968,530
  • Market Cap (intraday) 7.454B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.24
  • EPS (TTM) 8.22
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 106.47

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

www.hingehealth.com

1,437

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HNGE
98.86%
S&P 500 (^GSPC)
12.75%

1-Year Return

HNGE
64.92%
S&P 500 (^GSPC)
18.71%

3-Year Return

HNGE
133.85%
S&P 500 (^GSPC)
70.93%

5-Year Return

HNGE
133.85%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 212.82M
Earnings 43.69M
Profit Margin 20.53%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
50M
100M
150M
200M
0.0%
5.0%
10.0%
15.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

85.00
106.47 Average
92.37 Current
140.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/11/2026
Analyst Truist Securities
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 85 -> 112

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.15%

  • Return on Assets (ttm)

    7.70%

  • Return on Equity (ttm)

    30.38%

  • Revenue (ttm)

    720.06M

  • Net Income Avi to Common (ttm)

    107.28M

  • Diluted EPS (ttm)

    8.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    389.39M

  • Total Debt/Equity (mrq)

    1.71%

  • Levered Free Cash Flow (ttm)

    299.65M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: